» Articles » PMID: 38507902

High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers After Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2024 Mar 20
PMID 38507902
Authors
Affiliations
Soon will be listed here.
Abstract

Disruption of the glycosylation machinery is a common feature in many types of cancer, and colorectal cancer (CRC) is no exception. Core fucosylation is mediated by the enzyme fucosyltransferase 8 (FucT-8), which catalyzes the addition of α1,6-l-fucose to the innermost GlcNAc residue of -glycans. We and others have documented the involvement of FucT-8 and core-fucosylated proteins in CRC progression, in which we addressed core fucosylation in the syngeneic CRC model formed by SW480 and SW620 tumor cell lines from the perspective of alterations in their -glycosylation profile and protein expression as an effect of the knockdown of the gene that encodes FucT-8. Using label-free, semiquantitative mass spectrometry (MS) analysis, we found noticeable differences in -glycosylation patterns in -knockdown cells, affecting core fucosylation and sialylation, the Hex/HexNAc , and antennarity. Furthermore, stable isotopic labeling of amino acids in cell culture (SILAC)-based proteomic screening detected the alteration of species involved in protein folding, endoplasmic reticulum (ER) and Golgi post-translational stabilization, epithelial polarity, and cellular response to damage and therapy. This data is available via ProteomeXchange with identifier PXD050012. Overall, the results obtained merit further investigation to validate their feasibility as biomarkers of progression and malignization in CRC, as well as their potential usefulness in clinical practice.

Citing Articles

Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.

Xu H, Li Q, Zhang Y, He C, Zhang X, Wang Z Oncogenesis. 2025; 14(1):1.

PMID: 39881135 PMC: 11779920. DOI: 10.1038/s41389-025-00544-7.

References
1.
Lise M, Belluco C, Perera S, Patel R, Thomas P, Ganguly A . Clinical correlations of alpha2,6-sialyltransferase expression in colorectal cancer patients. Hybridoma. 2000; 19(4):281-6. DOI: 10.1089/027245700429828. View

2.
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J . STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014; 43(Database issue):D447-52. PMC: 4383874. DOI: 10.1093/nar/gku1003. View

3.
Liang Y, Wang T, Gao R, Jia X, Ji T, Shi P . Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients. Pathol Oncol Res. 2022; 28:1610116. PMC: 8883820. DOI: 10.3389/pore.2022.1610116. View

4.
Hayes C, Doohan R, Kirkley D, Leister K, Harhen B, Savage A . Cross validation of liquid chromatography-mass spectrometry and lectin array for monitoring glycosylation in fed-batch glycoprotein production. Mol Biotechnol. 2011; 51(3):272-82. DOI: 10.1007/s12033-011-9465-8. View

5.
Saini J, Sharma P . Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer. Curr Drug Targets. 2017; 19(13):1478-1490. DOI: 10.2174/1389450118666170823121248. View